The company employs more than 200 people across two UK facilities, although over three-quarters of its revenues come from customers in the US and mainland Europe.
Bridgepoint partner Alan Payne said, “Quotient Clinical serves a substantial and growing market and there is significant opportunity to increase market penetration thanks to its combination of unique service offering, strong regulatory governance and a talented management team.”
Quotient said the outsourced drug development market was currently valued at $30bn and is forecast to grow at up to six per cent each year.
Last month BDC acquired a minority stake in marine and engineering consultancy LOC Group, which serves the offshore oil and gas markets.
London-headquartered LOC Group operates from 30 offices across the globe and is currently a top three global provider of marine warranty surveys for the transport and installation of offshore equipment.
Copyright © 2013 AltAssets